Data / Crowdfunding / Washington / Deverra Therapeutics, Inc.
Deverra Therapeutics, Inc.: crowdfunding raise on StartEngine Capital, LLC, $14,999 to $1,234,999 (2024)
Deverra Therapeutics, Inc., a corporation in Seattle, WA, filed a Form C with the SEC on June 12, 2024 to raise $14,999 to $1,234,999 in common stock through StartEngine Capital, LLC. The offering closed on September 3, 2024. In its most recent fiscal year it reported $696,727 in revenue and a net loss of $1,523,035, with 1 employees.
SpecStream is the live web data engine for teams and agents. It reads every Form C on SEC EDGAR each morning, and this page is that reading. Ask for your own cut (a portal, a state, a size, a revenue range) and new raises arrive in your sheet, CRM, Slack or agent as they land.
- Website
- www.deverratx.com
- Funding portal
- StartEngine Capital, LLC
- Address
- 2033 6th Ave Suite 600, Seattle, WA 28121
- Legal form
- Corporation
- Jurisdiction
- DE
- Incorporated
- September 11, 2020
- SEC CIK
- 0001822782
Offering terms
From the amendment filed June 12, 2024.
- Security
- Common Stock
- Price
- $2.09
- Target
- $14,999
- Maximum
- $1,234,999
- Deadline
- September 3, 2024
- Portal compensation
- 7 - 13 percent
Financials
From the Form C-AR filed May 6, 2026.
| Most recent fiscal year | Prior fiscal year | Source | |
|---|---|---|---|
| Revenue | $696,727 | $3,879,188 | sec.gov |
| Cost of goods sold | $696,727 | $3,879,188 | sec.gov |
| Net income | $-1,523,035 | $-3,718,063 | sec.gov |
| Taxes paid | $29,694 | $72,893 | sec.gov |
| Total assets | $10,077,334 | $11,309,047 | sec.gov |
| Cash | $1,612 | $114 | sec.gov |
| Accounts receivable | $0 | $0 | sec.gov |
| Short-term debt | $1,435,000 | $1,690,073 | sec.gov |
| Long-term debt | $102,916 | $0 | sec.gov |
Filings
| Filed | Filing | Target | Maximum | Deadline | Note | Source |
|---|---|---|---|---|---|---|
| May 6, 2026 | Annual report | Not listed | Not listed | sec.gov | ||
| April 10, 2025 | Annual report | Not listed | Not listed | sec.gov | ||
| September 25, 2024 | Progress update | $14,999 | $1,234,999 | September 3, 2024 | At the close of the offering, the issuer closed on $971,017.53 and 505,584 number of securities. | sec.gov |
| June 12, 2024 | Amendment | $14,999 | $1,234,999 | September 3, 2024 | Issuer is extending campaign end date to September 3rd, 2024. | sec.gov |
| April 26, 2024 | Annual report | Not listed | Not listed | sec.gov | ||
| April 26, 2024 | Amendment | $14,999 | $1,234,999 | July 1, 2024 | Issuer is extending campaign end date to July 1st, 2024 and updating their financial statements per the most recent fiscal year. | sec.gov |
| March 28, 2024 | Offering | $14,999 | $1,234,999 | April 29, 2024 | sec.gov |
Also on SpecStream
Updated May 6, 2026. Read from SEC EDGAR. Public domain (U.S. government work). Financials are as each company reported them in its Form C, unaudited unless the filing says otherwise. Websites are the ones the companies declared to the SEC. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.